Q32 Bio
MA - Waltham
BiotechnologyFocus: Biologics to restore healthy immune regulation
Q32 Bio is a life sciences company focused on Biologics to restore healthy immune regulation.
Oncology
Open Jobs
0
Pipeline & Clinical Trials
ADX-914
Safety IssuesClinical Trials (1)
NCT04485481Single and Multiple Ascending Dose Study of ADX-914 in Healthy Adult Volunteers
Phase 1bempikibart
Alopecia AreataClinical Trials (1)
NCT06018428A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)
Phase 2ADX-097
IgA NephropathyClinical Trials (1)
NCT06419205A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G
Phase 2ADX-914
Atopic DermatitisClinical Trials (1)
NCT05509023Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 4 clinical trials
Top TAs: Immunology, Dermatology, Nephrology
Publications: 6 in PubMed
Hiring Trend
Stable
0
Open Roles
+0
Added
-0
Filled/Removed
Based on last 4 crawl cycles